All lobbying filings

CVS Health (And Subsidiaries)

CVS Health (And Subsidiaries) filed a Q2 report for CVS Health (And Subsidiaries) on July 21, 2025.

Lobbying for CVS Health (And Subsidiaries) · Health Care

As filed: CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES).

All filings by CVS Health (And Subsidiaries) · Everything CVS Health (And Subsidiaries) has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$1,810,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 7

Pharmacy

Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 P.L. 119-21 - The One Big, Beautiful Bill Act - issues related to retail pharmacy

Taxation/Internal Revenue Code

Issues related to corporate tax. P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. S.Con.Res.7 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act P.L. 119-21 - The One Big, Beautiful Bill Act - - issues related to Medicaid and PBMs

Insurance

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act P.L. 119-21 - The One Big, Beautiful Bill Act

Labor Issues/Antitrust/Workplace

Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. P.L. 119-21, The One Big, Beautiful Bill Act

Consumer Issues/Safety/Products

Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act

Advertising

S. 2068 - The End Prescription Drugs Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025

Bills named in this filing 13

H.R. 3164
Ensuring Community Access to Pharmacist Services Act
H.R. 3010
No Handouts for Drug Advertisements Act
S. 1785
No Handouts for Drug Advertisements Act
S. 882
Patients Before Middlemen Act
S. 927
Protecting Pharmacies in Medicaid Act
H. Con. Res. 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
S. Con. Res. 7
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal ye…
S. 1105
No UPCODE Act
H.R. 2214
DRUG Act
H.R. 2853
Combating Organized Retail Crime Act of 2025
S. 1404
Combating Organized Retail Crime Act
S. 2068
End Prescription Drug Ads Now Act
H.R. 3789
DTC Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.